PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CCL2 3,560 Target Target CXCL9 1,016 190 0.10 -0.88 0.19 0.80
Glomerulonephritis 23,459 Disease Disease Nephrotic Syndrome 14,681 2,479 0.13 -0.86 0.17 0.80
BMP-6 386 Target Target BMP-2 3,889 163 0.13 -0.74 0.42 0.80
Avandia (Rosiglitazone Maleate)- FDA 66 Drug Drug Amaryl (Glimepiride)- FDA 7 1 0.05 -0.92 0.14 0.80
Amlodipine Besylate (Norvasc)- FDA 28 Drug Drug Aquasol A (Vitamin A)- FDA 46 1 0.03 -0.97 0.04 0.80
Armodafinil (Nuvigil)- FDA 5 Drug Drug Aripiprazole (Abilify)- FDA 71 1 0.05 -0.89 0.20 0.80
Armodafinil (Nuvigil)- FDA 5 Drug Drug Abilify (Aripiprazole)- FDA 71 1 0.05 -0.89 0.20 0.80
Obsessive Compulsive Disorder 8,508 Disease Disease Anxiety Disorder 8,985 837 0.10 -0.90 0.10 0.80
Amantadine Hydrochloride (Symmetrel)- FDA 47 Drug Drug Ambien (Zolpidem Tartrate)- FDA 24 1 0.03 -0.97 0.04 0.80
Obsessive Compulsive Disorder 8,508 Disease Disease Panic Disorder 7,455 775 0.10 -0.90 0.10 0.80
CCL19 658 Target Target ELC 355 28 0.06 -0.94 0.08 0.80
CD1A 2,739 Target Target CD68 6,424 458 0.11 -0.88 0.17 0.80
Brain Tumors 16,749 Disease Disease Glioblastoma 17,933 2,018 0.12 -0.88 0.12 0.80
Adenosine A3 Receptor 164 Target Drug Ab-Meca 38 4 0.05 -0.93 0.11 0.80
D(1a) Dopamine Receptor 51 Target Target D(2) Dopamine Receptor 1,559 41 0.15 -0.44 0.80 0.80
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Drug Abecarnil 121 2 0.06 -0.86 0.25 0.80
Epiregulin 291 Target Target beta-Cellulin 17 6 0.09 -0.80 0.35 0.80
Atazanavir Sulfate (Reyataz)- FDA 40 Drug Drug Aldara (Imiquimod)- FDA 36 1 0.03 -0.97 0.03 0.80
Ascorbic Acid (Vitamin C)- FDA 20 Drug Drug Aquasol A (Vitamin A)- FDA 46 1 0.03 -0.96 0.05 0.80
Aldactone (Spironolactone)- FDA 18 Drug Drug Amantadine Hydrochloride (Symmetrel)- FDA 47 1 0.03 -0.96 0.06 0.80
CA 72-4 184 Target Target CA 15-3 898 34 0.08 -0.89 0.18 0.80
BAFF 1,240 Target Target BAFFR 44 33 0.14 -0.49 0.75 0.80
CCL2 3,560 Target Target CXCL2 750 192 0.12 -0.84 0.26 0.80
Azithromycin (Zithromax)- FDA 36 Drug Drug Accutane (Isotretinoin)- FDA 39 1 0.03 -0.97 0.03 0.80
EPHA3 140 Target Target EPHB1 137 5 0.04 -0.96 0.04 0.80
Avastin (Bevacizumab)- FDA 207 Drug Drug Alimta (Pemetrexed)- FDA 28 5 0.07 -0.90 0.18 0.80
CCL7 274 Target Target CXCL3 145 10 0.05 -0.95 0.07 0.80
BMX 185 Target Target BTK 1,263 49 0.10 -0.84 0.26 0.80
CAMK2D 21 Target Target CAMK4 43 1 0.03 -0.96 0.05 0.80
Abacavir Sulfate 41 Drug Drug Abacavir 1,496 41 0.17 -0.15 1.00 0.80
Atazanavir Sulfate (Reyataz)- FDA 40 Drug Drug Atorvastatin Calcium (Lipitor)- FDA 28 1 0.03 -0.97 0.04 0.80
Thromboembolism 23,698 Disease Disease Deep Vein Thrombosis 10,952 2,591 0.16 -0.82 0.24 0.80
CXCL10/IP-10 114 Target Target CXCL9 1,016 37 0.11 -0.81 0.32 0.81
Cytokeratin 8 587 Target Target Cytokeratin 18 1,108 60 0.07 -0.92 0.10 0.81
CCL7 274 Target Target CXCL2 750 34 0.08 -0.91 0.12 0.81
Panic Attack 823 Disease Disease Panic Disorder 7,455 444 0.18 -0.66 0.54 0.81
Antithrombin 13,773 Target Target D-Dimer 6,185 1,337 0.14 -0.84 0.22 0.81
Asenapine Sublingual Tablets (Saphris)- FDA 2 Drug Drug Aripiprazole (Abilify)- FDA 71 1 0.08 -0.70 0.50 0.81
Abilify (Aripiprazole)- FDA 71 Drug Drug Asenapine Sublingual Tablets (Saphris)- FDA 2 1 0.08 -0.70 0.50 0.81
CCN5 57 Target Target CYR61 539 17 0.10 -0.82 0.30 0.81
CCL7 274 Target Target CCL2 3,560 164 0.17 -0.62 0.60 0.81
EPHA4 357 Target Target EPHB1 137 14 0.06 -0.93 0.10 0.81
Cathepsin G 1,613 Target Target Elastase 13,875 985 0.21 -0.60 0.61 0.81
EPHB4 329 Target Target EPHB1 137 13 0.06 -0.93 0.09 0.81
Azithromycin (Zithromax)- FDA 36 Drug Drug Amphotericin B (Fungizone)- FDA 30 1 0.03 -0.97 0.03 0.81
Acamprosate Calcium (Campral)- FDA 30 Drug Drug Abilify (Aripiprazole)- FDA 71 2 0.04 -0.95 0.07 0.81
Acamprosate Calcium (Campral)- FDA 30 Drug Drug Aripiprazole (Abilify)- FDA 71 2 0.04 -0.95 0.07 0.81
Artemin 184 Target Target Enovin 3 3 0.13 -0.50 1.00 0.81
Epigen 27 Target Target Epiregulin 291 8 0.09 -0.83 0.30 0.81
Aldara (Imiquimod)- FDA 36 Drug Drug Atorvastatin Calcium (Lipitor)- FDA 28 1 0.03 -0.97 0.04 0.81